Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

218 results about "Medication cost" patented technology

Production method of enteric-coated kitasamycin for feed

The invention discloses a production method of enteric-coated kitasamycin for feed, which comprises the following process steps: step one, the preparation of drug-loaded pellets; step two, inner layer sustained-release coating of the drug-loaded pellets, which prolongs the release and acting time of kitasamycin; and steps three, outer layer enteric coating of the drug-loaded pellets, which ensures the release in succus entericus and small or no release in gastric juice. The method has the advantages that the kitasamycin is subjected to pellets pelletizing and 99 percent of the prepared granulums can pass through 24 meshes, so the dust is greatly reduced and the fluidity is increased; the coating of the inner layer sustained-release agent (HPMC) prolongs the release and acting time of the kitasamycin, reduces medication times and reduces the medication cost; and a layer of enteric substance, namely acrylic resin-III is sprayed and coated on the outer layer of particles. The substance protects the kitasamycin which is a weakly alkaline antibiotic from being damaged by gastroc acid in stomach, quickly disintegrates after entering enteric canal and releases the kitasamycin; and then the kitasamycin is absorbed by gastrointestinal mucosa into blood drug to play a role of restraining the reproduction of pathogenic microorganism and preventing diarrhea. Insoluble in the stomach, kitasamycin coating formulations have no pessimal stimulation on the stomach, and cannot result in regurgitation and vomiting. In addition, the sustained-release formulation, namely the kitasamycin prolongs the acting time so the medication times is reduced, the medication cost of farmers is reduced, and the economic benefit is improved.
Owner:WUXI ZHENGDA POULTRY

Sterilization composition containing benthiavalicarb isopropyl and bactericide for preventing and treating oomycetes

The invention discloses a sterilization composition containing benthiavalicarb isopropyl and bactericide for preventing and treating oomycetes, comprising a first active ingredient benthiavalicarb isopropyl and a second active ingredient which is one selected from bactericides for preventing and treating oomycetes, such as phosethyl-aluminium, cymoxanil, dimethomorph, benalaxyl, cyazofamid, fluopicolide, iprovalicarb and oxadixyl, wherein weight ratio of the first active ingredient to the second active ingredient is 0.05-5. The sterilization composition disclosed by the invention can be prepared into agriculturally allowable water dispersible granules, wettable powder or suspending agent. The sterilization composition disclosed by the invention is reasonable in components, good in sterilization effect and low in medication cost, and activity and sterilization effect of the sterilization composition are not simple addition of activities of each component; and compared with the existing single preparation, the sterilization composition disclosed by the invention has obvious synergistic effect besides obvious sterilization effect, is low in the medication cost, produces no pollution to crops, has good safety and accords with safety requirements of pesticide preparation, so that the sterilization composition disclosed by the invention has obvious control effect to downy mildew and epidemic disease of the crop.
Owner:农心作物科技股份有限公司

Bactericidal composition containing picoxystrobin and prochloraz and application of bactericidal composition

The invention relates to a bactericidal composition containing picoxystrobin and prochloraz and an application of the bactericidal composition, which belong to the technical field of pesticides. The invention discloses a bactericidal composition containing picoxystrobin and prochloraz or salts thereof, wherein the weight ratio of the picoxystrobin to the prochloraz or the salts thereof is 1:20-5:1. The composition can be prepared to agriculturally allowable suspending agent, water dispersible granules, wettable powder, missible oil, emulsion in water, microemulsion, etc. The bactericidal composition provided by the invention is reasonable in components, good in sterilization effect and low in medication cost, and the activity and sterilization effect of the bactericidal composition are not simple superposition of the activity of the components; compared with an existing single agent, besides having the excellent sterilization effect, the bactericidal composition is excellent in synergistic effect, capable of alleviating resistance, few in preparation residues, free of pollution on crops and good in safety, and furthermore, the bactericidal composition meets the safety requirements of pesticide preparations and has an obvious effect of preventing and treating anthracnose of fruit trees and vegetables, wheat powdery mildew, rice blast and banded sclerotial blight.
Owner:JIANGSU LVDUN PLANT PROTECTION AGROCHEM EXPERIMENTAL

Liraglutide multivesicular liposome and preparation method and application thereof

The invention relates to the field of medicines, and particularly relates to a liraglutide multivesicular liposome and a preparation method and an application thereof. The liraglutide multivesicular liposome provided by the invention comprises liraglutide, a membrane material, an osmotic pressure regulator and a stabilizer. The liraglutide multivesicular liposome prepared by the invention has goodstability, high drug encapsulation rate, large drug loading capacity, slow and steady drug release rate and no burst release phenomenon, significantly improves the bioavailability of the drug, thereby improving the curative effect, reduces dose-related side effects of the drug and medication cost and has a higher application value. Experiments shows that the liposome provided by the present invention can continuously release the drug in vitro for about 432 hours, and provide a stable blood concentration in vivo, significantly prolongs in-vivo retention time compared to other injections, showsobvious pharmacokinetic characteristics of a sustained release preparation, can provide a normal steady blood glucose level, plays hypoglycemic effect for 312 hours, and has the relative bioavailability of 661% to injections.
Owner:SHENYANG PHARMA UNIVERSITY

Insecticidal composition containing tolfenpyrad and ivermectin

The invention discloses an insecticidal composition containing tolfenpyrad and ivermectin, which comprises the following active ingredients, namely, tolfenpyrad and ivermectin, wherein the weight ratio of the tolfenpyrad to the ivermectin is 1: 65-65: 1, and the cumulant of the tolfenpyrad and the ivermectin is 0.5-78 percent of the weight of the insecticidal composition; and the insecticidal composition can be prepared into agriculturally allowable suspending agent, water dispersible granules, wettable powder, micro-capsule suspending agent, missible oil, emulsion in water or microemulsion or other dosage forms. The insecticidal composition has reasonable components, good insecticidal effect and low medication cost; in addition, the activity and the insecticidal effect of the insecticidal composition are not simple overlaying of the activities of various components; and compared with the traditional single preparation, the insecticidal composition has the advantages of remarkable insecticidal effect and synergistic effect, capability of retarding generation of resistance, less preparation residues, no pollution to crops, good safety, accordance with safety requirements of pesticide preparations and better control effects on rice steam borers, vegetable diamond back moths, beet armyworms, thrips, cotton bollworms, aphids and other insect pests.
Owner:GAUNGXI TIANYUAN BIOCHEM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products